ArticleCancer medicine2018
Population-based differences in the outcome and presentation of lung cancer patients based upon racial, histologic, and economic factors in all lung patients and those with metastatic disease.
Article in Cancer medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.
- Ethnic Differences in Survival Among Lung Cancer Patients: A Systematic Review.JNCI cancer spectrum · 2021Pooled it
- A meta-analysis comparing responses of Asian versus non-Asian cancer patients to PD-1 and PD-L1 inhibitor-based therapy.Oncoimmunology · 2020Pooled it
- Geospatial analysis as a tool for identification of potential targetable regions for lung cancer screening interventions in Massachusetts.Journal of thoracic disease · 2025Article
- Impact of Stage-Specific Guideline Concordant Treatment in Small Cell Lung Cancer in Victoria, Australia.Thoracic cancer · 2025Article
- Racial disparities in the cause of death among patients with lung cancer in the United States.Journal of thoracic disease · 2025Article
- Spatiotemporal disparities in the diagnosis, treatment, and mortality of respiratory tract cancers in Brazil.PloS one · 2025Article
- Mendelian randomization to explore the direct or mediating associations between socioeconomic status and lung cancer.Frontiers in oncology · 2023Article
- Article
- Article
- Clinical Implications of Nonbiological Factors With Colorectal Cancer Patients Younger Than 45 Years.Frontiers in oncology · 2021Article
- Socioeconomic factors affect treatment delivery for patients with low grade glioma: a Swedish population-based study.Journal of neuro-oncology · 2020Article
- A nomogram for the prediction of overall survival in patients with stage II and III non-small cell lung cancer using a population-based study.Oncology letters · 2019Article
- Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades.Cancer management and research · 2019Article
- Intracranial hemangioblastoma - A SEER-based analysis 2004-2013.Oncotarget · 2018Article
- Population-based differences in the outcome and presentation of lung cancer patients based upon racial, histologic, and economic factors in all lung patients and those with metastatic disease.Cancer medicine · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 6 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To investigate the interrelation between economic, marital, and known histopathologic/therapeutic prognostic factors in presentation and survival of patients with lung cancer in nine different ethnic groups. A retrospective review of the SEER database was conducted through the years 2007-2012. Population differences were assessed via chi-square testing. Multivariable analyses (MVA) were used to detect overall survival (OS) differences in the total population (TP, N = 153,027) and for those patients presenting with Stage IV (N = 70,968). Compared to Whites, Blacks were more likely to present with younger age, male sex, lower income, no insurance, single/widowed partnership, less squamous cell carcinomas, and advanced stage; and experience less definitive surgery, lower OS, and lung cancer-specific (LCSS) survival. White Hispanics presented with younger age, higher income, lower rates of insurance, single/widowed partnership status, advanced stage, more adenocarcinomas, and lower rates of definitive surgery, but no difference in OS and LCSS than Whites. In the TP and Stage IV populations, MVAs revealed that OS was better or equivalent to Whites for all other ethnic groups and was positively associated with insurance, marriage, and higher income. Blacks presented with more advanced disease and were more likely to succumb to lung cancer, but when adjusted for prognostic factors, they had a better OS in the TP compared to Whites. Disparities in income, marital status, and insurance rather than race affect OS of patients with lung cancer. Because of their presentation with advanced disease, Black and Hispanics are likely to have increased benefit from lung cancer screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.